Treating Lithium-Induced Nephrogenic Diabetes Insipidus With a COX-2 Inhibitor Improves Polyuria via Upregulation of AQP2 and NKCC2

American Journal of Physiology - Renal Physiology- United States

doi 10.1152/ajprenal.00366.2007

Full Text

Abstract

Available in

Categories

Date

April 1, 2008

Authors

Chong Myung Kang

Mark A. Knepper

Publisher

American Physiological Society

Related search

4-Pba Improves Lithium-Induced Nephrogenic Diabetes Insipidus by Attenuating ER Stress

American Journal of Physiology - Renal Physiology

English

Use of Amiloride in Lithium-Induced Nephrogenic Diabetes Insipidus

Journal of Analytical & Pharmaceutical Research

English

Use of Acetazolamide in Lithium-Induced Nephrogenic Diabetes Insipidus: A Case Report

Endocrinology, Diabetes and Metabolism Case Reports

Internal Medicine

English

Tamoxifen Attenuates Development of Lithium-Induced Nephrogenic Diabetes Insipidus in Rats

American Journal of Physiology - Renal Physiology

English

Prasugrel Suppresses Development of Lithium-Induced Nephrogenic Diabetes Insipidus in Mice

Purinergic Signalling

Molecular Neuroscience

Molecular Biology

English

Development of Lithium-Induced Nephrogenic Diabetes Insipidus Is Dissociated From Adenylyl Cyclase Activity

Journal of the American Society of Nephrology : JASN

English

Lithium-Induced Diabetes Insipidus.

English

Atorvastatin in the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus: The Protocol of a Randomized Controlled Trial

English

Physiopathology and Diagnosis of Nephrogenic Diabetes Insipidus

Annales d'Endocrinologie

English